HCA Midwest Health July 12, 2018

Dr. Stephanie Graff

Dr. Stephanie Graff, director of the Breast Program at the Sarah Cannon Cancer Institute at HCA Midwest Health, discusses the positive impact the clinical trial, TAILORx, will make with some women diagnosed with breast cancer. Additionally, she provides information on an exclusive study STRIVE, sponsored by GRAIL, Inc., happening right here at Menorah Medical Center and Centerpoint Medical Center.

About Our Breast Program